HIV disease severity and employment outcomes in affected households in Zambia

Nyasha Tirivayi and John R. Koethe
Additional contact information
Nyasha Tirivayi: UNU-MERIT

No 2015-018, MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT)

Abstract: The relationship between immune status and employment outcomes in HIV-infected patients on long-term antiretroviral therapy (ART) in sub-Saharan Africa and their HIV-affected households is not well understood. We assessed the relationship between CD4+ T-cell counts of ART-treated adults at public-sector clinics in Lusaka, Zambia (median treatment duration 973 days) and labour force participation in the HIV-affected households using clinical and survey data. In multivariable models, patients with a CD4+ count >350 cells/µl were 22 percentage points more likely to be engaged in labour (95% CI: 0.02, 0.42) and worked approximately 6 more days per month compared to patients with a CD4+ count

Keywords: HIV; Aids; Africa; Zambia; CD4 count; employment; labour force; household; household welfare (search for similar items in EconPapers)
JEL-codes: I10 I18 J22 (search for similar items in EconPapers)
Date: 2015
New Economics Papers: this item is included in nep-afr, nep-dev and nep-hea
References: Add references at CitEc
Citations:

Downloads: (external link)
https://unu-merit.nl/publications/wppdf/2015/wp2015-018.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:unm:unumer:2015018

Access Statistics for this paper

More papers in MERIT Working Papers from United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) Contact information at EDIRC.
Bibliographic data for series maintained by Ad Notten ( this e-mail address is bad, please contact ).